Improving the immunogenicity of HIV-1 envelope trimer vaccines

le Sanders Rogier W
Foilsithe 2011-10-01

Improving the immunogenicity of HIV-1 envelope trimer vaccines

le Sanders, Rogier W
Foilsithe 2011

HIV takes double hit before entry

le Sanders, Rogier W
Foilsithe 2012

A stamp on the envelope

le SANDERS, ROGIER W., MOORE, JOHN P.
Foilsithe in Nature (2014)

Native‐like Env trimers as a platform for HIV‐1 vaccine design

le Sanders, Rogier W., Moore, John P.
Foilsithe in Immunol Rev (2017)

Virus vaccines: proteins prefer prolines

le Sanders, Rogier W., Moore, John P.
Foilsithe in Cell Host Microbe (2021)

Opposites attract in bispecific antibody engineering

le van Gils, Marit J., Sanders, Rogier W.
Foilsithe in J Biol Chem (2017)

Presentation of HIV-1 envelope glycoprotein trimers on diverse nanoparticle platforms

le Brouwer, Philip J.M., Sanders, Rogier W.
Foilsithe in Curr Opin HIV AIDS (2019)

Pandemic moves and countermoves: vaccines and viral variants

le Sanders, Rogier W, de Jong, Menno D
Foilsithe in Lancet (2021)

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies

le Torrents de la Peña, Alba, Sanders, Rogier W.
Foilsithe in Retrovirology (2018)

Targeting B-cell germlines and focusing affinity maturation: the next hurdles in HIV-1-vaccine development?

le Medina-Ramírez, Max, Sanders, Rogier W., Klasse, Per Johan
Foilsithe 2014

Stabilized HIV-1 envelope glycoprotein trimers for vaccine use

le Medina-Ramírez, Max, Sanders, Rogier W., Sattentau, Quentin J.
Foilsithe in Curr Opin HIV AIDS (2017)

Enhanced Immunogenicity of HIV-1 Envelope gp140 Proteins Fused to APRIL

le Isik, Gözde, Sliepen, Kwinten, van Montfort, Thijs, Sanders, Rogier W.
Foilsithe 2014

HIV-1 envelope trimer design and immunization strategies to induce broadly neutralizing antibodies

le de Taeye, Steven W., Moore, John P., Sanders, Rogier W.
Foilsithe in Trends Immunol (2016)

Evolution of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat Promoter by Conversion of an NF-κB Enhancer Element into a GABP Binding Site

le Verhoef, Koen, Sanders, Rogier W., Fontaine, Veronique, Kitajima, Shigetaka, Berkhout, Ben
Foilsithe 1999

How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development?

le Klasse, Per Johan, Sanders, Rogier W., Cerutti, Andrea, Moore, John P.
Foilsithe 2012

V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc

le Berro, Reem, Klasse, Per Johan, Moore, John P., Sanders, Rogier W.
Foilsithe 2012

Harnessing post-translational modifications for next generation HIV immunogens

le Allen, Joel D., Sanders, Rogier W., Doores, Katie J., Crispin, Max
Foilsithe in Biochem Soc Trans (2018)

Env exceptionalism – Why are HIV-1 Env glycoproteins atypical immunogens?

le Klasse, P. J., Ozorowski, Gabriel, Sanders, Rogier W., Moore, John P.
Foilsithe in Cell Host Microbe (2020)

Immunosilencing a Highly Immunogenic Protein Trimerization Domain

le Sliepen, Kwinten, van Montfort, Thijs, Melchers, Mark, Isik, Gözde, Sanders, Rogier W.
Foilsithe in J Biol Chem (2015)